日本語フィールド
著者：○Takahashi H, Kessoku T, Kawanaka M , Nonaka M, Hyogo H , Fujii H, Nakajima T, Imajo K, Tanaka K , Kubotsu Y, Isoda H , Oeda S, Kurai O , Yoneda M, Ono M , Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Anzai K , Nakajima A, Eguchi Y題名：Resolution of non-alcoholic steatohepatitis and hepatic fibrosis by sodium glucose transporter-2 inhibitor, ipragliflozin; a multicenter randomized controlled trial.発表情報：THE DEGITAL INTERNATIONAL LIVER CONGRESS 2020, 2020, 8, 27-29（until 31 December 2020 : on demand）キーワード：概要：抄録：JOURNAL OF HEPATOLOGY The Home of Liver Research S138-139 VOLUME 73 Suppl. 1:AUGUST 2020英語フィールド
Author：○Takahashi H, Kessoku T, Kawanaka M , Nonaka M, Hyogo H , Fujii H, Nakajima T, Imajo K, Tanaka K , Kubotsu Y, Isoda H , Oeda S, Kurai O , Yoneda M, Ono M , Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Anzai K , Nakajima A, Eguchi YTitle：Resolution of non-alcoholic steatohepatitis and hepatic fibrosis by sodium glucose transporter-2 inhibitor, ipragliflozin; a multicenter randomized controlled trial.Announcement information:THE DEGITAL INTERNATIONAL LIVER CONGRESS 2020, 2020, 8, 27-29（until 31 December 2020 : on demand）An abstract：JOURNAL OF HEPATOLOGY The Home of Liver Research S138-139 VOLUME 73 Suppl. 1:AUGUST 2020